Objectives To determine the time interval between mifepristone and misoprostol
administration associated with the most efficacious early pregnancy loss (EPL) …

Objective: To determine the safety and effectiveness of managing intrauterine death after 24
weeks gestation using a combination of mifepristone and misoprostol. Study design: Two …

Objective Simultaneous mifepristone 200 mg and vaginal misoprostol 800 μg produces a
complete abortion rate of approximately 90% at up to 63 days of gestation. The aim of this …

Importance Early pregnancy loss (EPL) is the most common complication of pregnancy. A
multicenter randomized clinical trial compared 2 strategies for medical management and …

Introduction We aimed to assess the feasibility and acceptability of a second-trimester
medical abortion regimen using mifepristone and sublingual misoprostol with no maximum …

Objective To compare the efficacy of a shorter interval (24 hours) between misoprostol and
mifepristone administration with that of the conventional dosing interval (48 hours) for …

OBJECTIVE: To assess the risk difference of uterine rupture when using current mifepristone
and misoprostol regimens for second-trimester abortion among individuals with prior …

Objective To update our 2019 systematic review of data on the effectiveness and safety of
misoprostol-only for first-trimester abortion. Study design We searched PubMed on 18 …

Objective To compare the effectiveness and safety of repeat misoprostol versus expectant
management in women with first‐trimester incomplete miscarriage who have been initially …

Background: Mifepristone became available in New Zealand in 2001, and was first used for
second trimester terminations at the Level J Unit, Wellington Hospital. The protocol is based …